Literature DB >> 1410529

Opioid peptides are substrates for the bifunctional enzyme LTA4 hydrolase/aminopeptidase.

K J Griffin1, J Gierse, G Krivi, F A Fitzpatrick.   

Abstract

We determined if any naturally occurring peptides could act as substrates or inhibitors of the bifunctional, Zn2+ metalloenzyme LTA4 hydrolase/aminopeptidase (E.C.3.3.2.6). Several opioid peptides including met5-enkephalin, leu5-enkephalin, dynorphin1-6, dynorphin1-7, and dynorphin1-8 competitively inhibited the hydrolysis of L-proline-p-nitroanilide by leukotriene A4 hydrolase/aminopeptidase, consistent with an interaction at its active site. The enzyme catalyzed the N-terminal hydrolysis of tyrosine from met5-enkephalin with Km = 450 +/- 58 microM and Vmax = 4.9 +/- 0.6 nmol-hr-1-ug-1 and from leu5-enkephalin with Km = 387 +/- 90 microM and Vmax = 6.2 +/- 2.5 nmol-hr-1-ug-1. Bestatin, captopril and carnosine inhibited the hydrolysis of the enkephalins. It is noteworthy that the bifunctional catalytic traits of this enzyme include generation of an hyperalgesic substance, LTB4, and inactivation of analgesic opioid peptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410529     DOI: 10.1016/0090-6980(92)90018-o

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  7 in total

Review 1.  Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis.

Authors:  J Z Haeggström
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.

Authors:  L Iversen; B Deleuran; A M Hoberg; K Kragballe
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

3.  Substrate-dependent modulation of the leukotriene A4 hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammation.

Authors:  Kyung Hyeon Lee; Nadia Fazal Ali; Soo Hyeon Lee; Zhimin Zhang; Marie Burdick; Zachary J Beaulac; Greg Petruncio; Linxia Li; Jiangdong Xiang; Ezra M Chung; Kenneth W Foreman; Schroeder M Noble; Yun M Shim; Mikell Paige
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

4.  Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.

Authors:  Ahamed Hossain; David Heron; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Shusheng Wang; Partha S Bhattacharjee
Journal:  Exp Eye Res       Date:  2016-06-23       Impact factor: 3.467

5.  Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.

Authors:  M J Mueller; A Wetterholm; M Blomster; H Jörnvall; B Samuelsson; J Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

6.  The Analgesic Activity of Bestatin as a Potent APN Inhibitor.

Authors:  Mei-Rong Jia; Tao Wei; Wen-Fang Xu
Journal:  Front Neurosci       Date:  2010-06-28       Impact factor: 4.677

7.  Identification and prioritization of novel uncharacterized peptidases for biochemical characterization.

Authors:  Neil D Rawlings
Journal:  Database (Oxford)       Date:  2013-04-12       Impact factor: 3.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.